Luciano Ibba (L Ibba)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 40

Top Topics

Monoclonal Antibody

Atopic Dermatitis

Clinical Practice

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

Dermatology and therapy

Clinical drug investigation

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Giovanni Fiorillo, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti
Effectiveness and Safety of Biological Therapies in Very Severe Plaque Psoriasis: A Real-Life Retrospective Study. Journal of personalized medicine 14 (2) (2024)
Luigi Gargiulo, Luciano Ibba, P Malagoli, F Amoruso, Anna Balato, F Bardazzi, M Burlando, C G Carrera, P Dapavo, Valentina Dini, Francesca Maria Gaiani, Giampiero Girolomoni, C Guarneri, C Lasagni, F Loconsole, Angelo Valerio Marzano, Martina Maurelli, Matteo Megna, M Travaglini, Antonio Costanzo, A Narcisi
Long-term effectiveness and tolerability of apremilast in patients with moderate-to-severe plaque psoriasis: A 5-year multicentre retrospective study-IL PSO (Italian landscape psoriasis). Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Luigi Gargiulo, Luciano Ibba, F Piscazzi, F Amoruso, A Balato, Francesca Barei, Martina Bertello, A G Burroni, S Caccavale, S M Ferrucci, C Foti, Francesca Maria Gaiani, Giampiero Girolomoni, P Malagoli, Angelo Valerio Marzano, Martina Maurelli, Maddalena Napolitano, E Nettis, M Ortoncelli, C Patruno, E Pezzolo, Simone Ribero, P Romita, M T Rossi, I Zaza, M B Guanti, Antonio Costanzo, A Narcisi
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Anna G Burroni, Andrea Chiricozzi, Paolo Dapavo, Silvia M Ferrucci, Massimo Gola, Maddalena Napolitano, Michela Ortoncelli, Maria T Rossi, Claudio Sciarrone, Antonio Costanzo, Alessandra Narcisi
Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus. Dermatology and therapy (2024)
Mario Valenti, Luigi Gargiulo, Luciano Ibba, Andrea Cortese, Francesco Toso, Diego Orsini, Viviana Lora, Pasquale Frascione, Paolo Sena, Andrea Carugno, Chiara Assorgi, Antonio Costanzo, Alessandra Narcisi
Effectiveness of ixekizumab for the treatment of moderate-to-severe plaque psoriasis with involvement of difficult-to-treat areas: A 52-week multicenter retrospective study. The Journal of dermatology 51 (6) (2024)
Giovanni Fiorillo, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti
Effectiveness and Safety of Biological Therapies in Very Severe Plaque Psoriasis: A Real-Life Retrospective Study. Journal of personalized medicine 14 (2) (2024)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Anna G Burroni, Andrea Chiricozzi, Paolo Dapavo, Silvia M Ferrucci, Massimo Gola, Maddalena Napolitano, Michela Ortoncelli, Maria T Rossi, Claudio Sciarrone, Antonio Costanzo, Alessandra Narcisi
Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus. Dermatology and therapy 14 (4) (2024)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Anna G Burroni, Andrea Chiricozzi, Paolo Dapavo, Silvia M Ferrucci, Massimo Gola, Maddalena Napolitano, Michela Ortoncelli, Maria T Rossi, Claudio Sciarrone, Antonio Costanzo, Alessandra Narcisi
Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus. Dermatology and therapy 14 (4) (2024)
Luigi Gargiulo, Luciano Ibba, F Piscazzi, F Amoruso, A Balato, Francesca Barei, Martina Bertello, A G Burroni, S Caccavale, S M Ferrucci, C Foti, Francesca Maria Gaiani, Giampiero Girolomoni, P Malagoli, Angelo Valerio Marzano, Martina Maurelli, Maddalena Napolitano, E Nettis, M Ortoncelli, C Patruno, E Pezzolo, Simone Ribero, P Romita, M T Rossi, I Zaza, M B Guanti, Antonio Costanzo, A Narcisi
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Anna G Burroni, Andrea Chiricozzi, Paolo Dapavo, Silvia M Ferrucci, Massimo Gola, Maddalena Napolitano, Michela Ortoncelli, Maria T Rossi, Claudio Sciarrone, Antonio Costanzo, Alessandra Narcisi
Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus. Dermatology and therapy 14 (4) (2024)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Giuseppe Argenziano, Anna Balato, Federico Bardazzi, Martina Burlando, Carlo Giovanni Carrera, Giovanni Damiani, Paolo Dapavo, Valentina Dini, Chiara Franchi, Francesca Maria Gaiani, Giampiero Girolomoni, Claudio Guarneri, Claudia Lasagni, Francesco Loconsole, Angelo Valerio Marzano, Martina Maurelli, Matteo Megna, Orsini Diego, Francesca Sampogna, Massimo Travaglini, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study-IL PSO (ITALIAN LANDSCAPE PSORIASIS). Journal of clinical medicine 13 (2) (2024)
Matteo Bianco, Sara Di Giulio, Arturo Bonometti, Luca L Mancini, Luciano Ibba, Antonio Costanzo, Alessandra Narcisi, Luigi Gargiulo
Erythroderma in the spectrum of thymoma-associated multiorgan autoimmunity (TAMA) syndrome: a case report of a patient with thymoma and myasthenia gravis. International journal of dermatology (2024)
Gianluca Tavoletti, Alessandra Chiei-Gallo, Luigi Gargiulo, Gianluca Avallone, Luciano Ibba, Francesca Barei, Paolo Calzari, Alessandra Narcisi, Angelo Valerio Marzano, Silvia Mariel Ferrucci
Effectiveness of dupilumab in tralokinumab-resistant patients with atopic dermatitis: A real-world experience from two referral centres. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Giovanni Fiorillo, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti
Effectiveness and Safety of Biological Therapies in Very Severe Plaque Psoriasis: A Real-Life Retrospective Study. Journal of personalized medicine 14 (2) (2024)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Giuseppe Argenziano, Anna Balato, Federico Bardazzi, Martina Burlando, Carlo Giovanni Carrera, Giovanni Damiani, Paolo Dapavo, Valentina Dini, Chiara Franchi, Francesca Maria Gaiani, Giampiero Girolomoni, Claudio Guarneri, Claudia Lasagni, Francesco Loconsole, Angelo Valerio Marzano, Martina Maurelli, Matteo Megna, Orsini Diego, Francesca Sampogna, Massimo Travaglini, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study-IL PSO (ITALIAN LANDSCAPE PSORIASIS). Journal of clinical medicine 13 (2) (2024)
Luigi Gargiulo, Luciano Ibba, F Piscazzi, F Amoruso, A Balato, Francesca Barei, Martina Bertello, A G Burroni, S Caccavale, S M Ferrucci, C Foti, Francesca Maria Gaiani, Giampiero Girolomoni, P Malagoli, Angelo Valerio Marzano, Martina Maurelli, Maddalena Napolitano, E Nettis, M Ortoncelli, C Patruno, E Pezzolo, Simone Ribero, P Romita, M T Rossi, I Zaza, Antonio Costanzo, A Narcisi
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Mario Valenti, Luigi Gargiulo, Luciano Ibba, Andrea Cortese, Francesco Toso, Diego Orsini, Viviana Lora, Pasquale Frascione, Paolo Sena, Andrea Carugno, Chiara Assorgi, Antonio Costanzo, Alessandra Narcisi
Effectiveness of ixekizumab for the treatment of moderate-to-severe plaque psoriasis with involvement of difficult-to-treat areas: A 52-week multicenter retrospective study. The Journal of dermatology 51 (6) (2024)
Mario Valenti, Luigi Gargiulo, Luciano Ibba, Andrea Cortese, Francesco Toso, Diego Orsini, Viviana Lora, Pasquale Frascione, Paolo Sena, Andrea Carugno, Chiara Assorgi, Antonio Costanzo, Alessandra Narcisi
Effectiveness of ixekizumab for the treatment of moderate-to-severe plaque psoriasis with involvement of difficult-to-treat areas: A 52-week multicenter retrospective study. The Journal of dermatology (2024)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Anna G Burroni, Andrea Chiricozzi, Paolo Dapavo, Silvia M Ferrucci, Massimo Gola, Maddalena Napolitano, Michela Ortoncelli, Maria T Rossi, Claudio Sciarrone, Antonio Costanzo, Alessandra Narcisi
Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus. Dermatology and therapy 14 (4) (2024)
Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, M Valenti, P Sierzputowska, Antonio Costanzo, A Narcisi
Pregnancy outcome of a patient treated with upadacitinib for severe atopic dermatitis. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Rosa Giuseppa Angileri, Federico Bardazzi, Nicoletta Bernardini, Martina Burlando, Carlo G Carrera, Andrea Chiricozzi, Paolo Dapavo, Valentina Dini, Gabriella Fabbrocini, Francesca Maria Gaiani, Marco Galluzzo, Claudia Giofré, Claudio Guarneri, Francesco Loconsole, Giovanna Malara, Lorenzo Marcelli, Matteo Megna, Stefano Piaserico, Marina Talamonti, Antonio Costanzo, Alessandra Narcisi
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS). Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Luigi Gargiulo, Luciano Ibba, Andrea Cortese, Jessica Avagliano, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study. Dermatology and therapy 13 (2) (2023)
Luigi Gargiulo, Luciano Ibba, Andrea Cortese, Angela Alfano, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Intra-Class Switch Among IL-23 Inhibitors for Plaque Psoriasis: Is It Worth It? Clinical drug investigation (2023)
Luigi Gargiulo, Luciano Ibba, Andrea Cortese, Jessica Avagliano, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study. Dermatology and therapy (2023)
Luigi Gargiulo, Luciano Ibba, Andrea Cortese, Angela Alfano, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Intra-Class Switch Among IL-23 Inhibitors for Plaque Psoriasis: Is It Worth It? Clinical drug investigation 43 (5) (2023)
Luigi Gargiulo, Luciano Ibba, P Malagoli, R G Angileri, F Bardazzi, Nicoletta Bernardini, M Burlando, C G Carrera, Andrea Chiricozzi, P Dapavo, Valentina Dini, G Fabbrocini, F M Gaiani, Marco Galluzzo, C Giofré, C Guarneri, F Loconsole, G Malara, L Marcelli, Matteo Megna, Stefano Piaserico, Marina Talamonti, Antonio Costanzo, A Narcisi
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: a 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS). Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Rosa Giuseppa Angileri, Federico Bardazzi, Nicoletta Bernardini, Martina Burlando, Carlo G Carrera, Andrea Chiricozzi, Paolo Dapavo, Valentina Dini, Gabriella Fabbrocini, Francesca Maria Gaiani, Marco Galluzzo, Claudia Giofré, Claudio Guarneri, Francesco Loconsole, Giovanna Malara, Lorenzo Marcelli, Matteo Megna, Stefano Piaserico, Marina Talamonti, Antonio Costanzo, Alessandra Narcisi
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS). Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Luigi Gargiulo, Luciano Ibba, Andrea Cortese, Angela Alfano, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Intra-Class Switch Among IL-23 Inhibitors for Plaque Psoriasis: Is It Worth It? Clinical drug investigation 43 (5) (2023)
Giovanni Fiorillo, Luciano Ibba, Luigi Gargiulo, C A Vignoli, A Alfano, Andrea Cortese, F Toso, D Orsini, P Iacovelli, P Frascione, A Narcisi, Antonio Costanzo, M Valenti
Effectiveness and safety of anti-IL-23 and anti-IL-17 biological therapies for psoriasis in elderly patients: real-world experience from two Italian hospitals. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Luigi Gargiulo, Luciano Ibba, P Malagoli, F Amoruso, Giuseppe Argenziano, Anna Balato, F Bardazzi, M Burlando, C G Carrera, Giovanni Damiani, P Dapavo, Valentina Dini, G Fabbrocini, C Franchi, F M Gaiani, Giampiero Girolomoni, C Guarneri, C Lasagni, F Loconsole, Angelo Valerio Marzano, Martina Maurelli, Matteo Megna, D Orsini, Francesca Sampogna, M Travaglini, M Valenti, Antonio Costanzo, A Narcisi
A Risankizumab Super Responder Profile Identified by Long-term Real-Life Observation- IL PSO (ITALIAN LANDSCAPE PSORIASIS). Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Luigi Gargiulo, Luciano Ibba, Mario Valenti, Diego Orsini, Antonio Cristaudo, Pasquale Frascione, Antonio Costanzo, Alessandra Narcisi
Safety of Interleukin Inhibitors in Patients with Plaque Psoriasis and Neoplasm: A Retrospective Study from Two Referral Centers. Clinical drug investigation (2023)
Diego Orsini, Fabio S Maramao, Luigi Gargiulo, Luciano Ibba, Francesco Piscazzi, Alessia Pacifico, Alessandra Latini, Laura Gianserra, Antonio Cristaudo, Antonio Costanzo, Alessandra Narcisi
Effectiveness and safety of risankizumab in HIV patients with psoriasis: A case series. International journal of STD & AIDS (2023)
Orsini Diego, P Frascione, C Assorgi, A Pacifico, I Sperduti, Luigi Gargiulo, Luciano Ibba, Mario Valenti, Antonio Costanzo, A Narcisi
Risankizumab for the treatment of genital psoriasis: a 1-year, real-world experience. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Luigi Gargiulo, Luciano Ibba, Andrea Cortese, Angela Alfano, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Intra-Class Switch Among IL-23 Inhibitors for Plaque Psoriasis: Is It Worth It? Clinical drug investigation 43 (5) (2023)
Luigi Gargiulo, Luciano Ibba, Andrea Cortese, Jessica Avagliano, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study. Dermatology and therapy (2023)
Luigi Gargiulo, Luciano Ibba, Giulia Pavia, Carlo Alberto Vignoli, Francesco Piscazzi, Mario Valenti, Federica Sanna, Chiara Perugini, Jessica Avagliano, Antonio Costanzo, Alessandra Narcisi
Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study. Dermatology and therapy 12 (10) (2022)
Mario Valenti, Luigi Gargiulo, Luciano Ibba, Giulia Pavia, Alessandra Narcisi, Antonio Costanzo
Sub-erythrodermic psoriasis successfully treated with bimekizumab: A case report. Dermatologic therapy (2022)
Luciano Ibba, Luigi Gargiulo, Casana Maddalena, Francesco Sacrini, Alessandra Narcisi, Paola Morelli, Antonio Costanzo, Luca Livio Mancini
Monkeypox infection with perianal lesions, fever, and lymphadenopathy. International journal of dermatology (2022)
Alessandra Narcisi, Mario Valenti, Luigi Gargiulo, Luciano Ibba, Fabrizio Amoruso, Giuseppe Argenziano, Federico Bardazzi, Martina Burlando, Carlo Giovanni Carrera, Giovanni Damiani, Paolo Dapavo, Valentina Dini, Chiara Franchi, Giampiero Girolomoni, Claudio Guarneri, Francesco Loconsole, Francesca Sampogna, Massimo Travaglini, Piergiorgio Malagoli, Antonio Costanzo
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis). Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Cristina Piras, Antonio Noto, Luciano Ibba, Martino Deidda, Vassilios Fanos, Sandro Muntoni, Vera Piera Leoni, Luigi Atzori
Contribution of Metabolomics to the Understanding of NAFLD and NASH Syndromes: A Systematic Review. Metabolites 11 (10) (2021)